콜마비앤에이치
Financials
Valuation Metrics
콜마비앤에이치's Market Cap is ₩2227B. At end of 2025 it was ₩3683B. Ranked #799 of 2,421 in KR market (top 33%), #362 of 1,640 on KOSDAQ (top 22%), #21 of 57 in Household & Personal Products (top 37%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 222.72B KRW | KR#799/2,421 Sec#21/57 |
| Revenue | 538.18B KRW | KR#594/2,421 Sec#12/57 |
| Net Income | -1.48B KRW | KR—/2,421 Sec—/57 |
| Total Assets | 570.69B KRW | KR#715/2,421 Sec#11/57 |
| Net Assets | 382.68B KRW | KR#611/2,421 Sec#10/57 |
| Employees | 528 | KR#469/2,421 Sec#10/57 |
| Value | ||
| P/B | 0.58x | KR#958/2,421 Sec#19/57 |
| P/S | 0.41x | KR#791/2,421 Sec#11/57 |
| EV/EBITDA | 7.75x | KR#453/2,421 Sec#7/57 |
| FCF Yield | 10.08% | KR#605/2,421 Sec#9/57 |
| Profitability | ||
| ROE | -0.39% | KR#1,576/2,421 Sec#37/57 |
| ROA | -0.26% | KR#1,582/2,421 Sec#37/57 |
| Op. Margin | 6.10% | KR#826/2,421 Sec#21/57 |
| Revenue Growth | -8.83% | KR#1,899/2,421 Sec#45/57 |
| Financial Health | ||
| Debt Ratio | 49.13% | KR#951/2,421 Sec#27/57 |
| Total Debt | 108.06B KRW | KR#699/2,421 Sec#11/57 |
| FCF | 22.45B KRW | KR#487/2,421 Sec#12/57 |
| Cash | 76.12B KRW | KR#575/2,421 Sec#15/57 |
| Current Ratio | 2.52x | KR#684/2,421 Sec#17/57 |
| Net Debt/EBITDA | 0.97x | KR#732/2,421 Sec#20/57 |
| Dividend | ||
| Div. Yield | 8.79% | KR#54/2,421 Sec#1/57 |
| Div. Growth | -75.65% | KR—/2,421 Sec—/57 |
| Performance | ||
| 1Y Return | -52.95% | KR#2,109/2,421 Sec#50/57 |
| 1M Return | -15.87% | KR#2,255/2,421 Sec#53/57 |
| From 52W High | -53.71% | KR#1,576/2,421 Sec#41/57 |
| 1Y MDD | -53.54% | KR#1,149/2,421 Sec#35/57 |
| Trading | ||
| Volume | 50,586 shares | KR#1,123/2,421 Sec#28/57 |
| Trading Value | 392.7M KRW | KR#1,024/2,421 Sec#25/57 |
| Foreign Own. | 3.19% | KR#1,232/2,421 Sec#23/57 |
| Per Share | ||
| EPS | -52 KRW | KR—/2,421 Sec—/57 |
| BPS | 13,299 KRW | KR#782/2,421 Sec#17/57 |
Company Info
Established in 2004, this company specializes in research and development of health functional food and cosmetic materials, listed on KOSDAQ in 2015. It commercializes natural product-based materials to produce health functional foods and cosmetics via ODM/OEM, operating multiple domestic sites and three overseas corporations in China and Australia, along with subsidiaries H&G Co., Ltd. and Geuno Nongrim Co., Ltd. The company supplies diverse products for immune function improvement, gut health improvement, and blood sugar improvement to 26 countries. Kolmar B&H, established in 2014, is headquartered in Jeonui-myeon, Sejong Special Self-Governing City.